GHSI

Guardion Health Sciences, Inc. (GHSI) | Rumor.io

Guardion Health Sciences

GHSI

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)—

Price to earnings ratio0

Market capitalization0

Earnings per share0

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)0

Social

What share of all stock conversation is about GHSI?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Oct 1

The company's performance has been criticized for being "lazy" and "incompetent", with some questioning the handling of the sale of Viactiv and the departure of Jan with a "golden parachute".
Shareholders have expressed frustration with the company's handling of the dissolution process, with some expecting a loss on their investment despite receiving a special dividend.
The company's stock price has been impacted by the dissolution plan, with some investors holding out hope for a potential turnaround despite the challenges facing the company.

Generated by AI

Sentiment

Of the messages about GHSI that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	33.33% -43.92
Bearish	—	—	—	66.67% +43.92

Bullish· Aug 30

$GHSI is expected to reach $30 due to an upcoming $5 dividend in September.
The stock has a high potential for an "epic squeeze" as shorts have 20 days to cover their positions and the dividend will be paid in September.
A breakout above $14.30 could set up a higher move to $20, driven by increasing volume and a battle between buyers and sellers.

Bearish· Aug 28

$GHSI is expected to be liquidated and dissolved by the end of September 2024, with estimated distributions to shareholders ranging from $9.00 to $11.00 per share.
The company's CEO and largest shareholder have taken significant losses, with the CEO selling shares and the largest shareholder exiting the position above $11.00.
The stock has experienced a sharp decline, with a 43.13% drop in three days, and is likely to continue bleeding out as the liquidation date approaches.

Generated by AI

Topics

Of the messages about GHSI that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	0%
Announcements	—	—	—	100%
Controversies	—	—	—	0%
Earnings	—	—	—	0%
Macro	—	—	—	0%
Technical Analysis	—	—	—	0%

Announcements· Jan 6

Guardion Health Sciences, Inc. (GHSI) is expected to have significant revenue and profit growth under the leadership of Bret Scholtes, a seasoned executive with a track record of success in the nutritional products industry.
Scholtes' compensation package is structured to align with the primary goal of increasing stockholder value, focusing on product and market development to drive revenue growth and profitability.
Guardion Health Sciences has been identified as a leader in the healthcare sector, with the company's stock price experiencing a significant increase following the appointment of Scholtes as CEO.

Technical Analysis· Aug 26

$GHSI is considered a low-risk swing trade after dropping from $20 to $13.
Technical analysis suggests $GHSI could reach triple digits if shorts do not learn their lesson.
The stock's chart is seen as bullish, with potential for a price increase driven by fomo before September 4.

Generated by AI

Community

Of the messages about GHSI, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	6.38%
Newcomers	—	—	—	93.62%

Regulars· May 26

$GHSI has crossed over VWAP again, with a 5.2% gain and a float of 23.6M, and a short float of 27.8%.
$GHSI has made a new float rotation (count: 2), with a 5.2% gain and a float of 23.6M, and a short float of 27.8%.
$GHSI could be squeezing due to high volume compared to its shares float, with a float rotation count of 5, a 5.2% gain, and a float of 23.6M.

Newcomers· Mar 28

The stock price of GHSI experienced significant volatility, with a large number of shares traded at the opening and a steep decline later in the day.
Short interest in GHSI has increased, according to a recent scan, indicating a potential opportunity for a "nice little runner".
The stock was halted twice on the same day due to high volatility, with the second halt occurring at 13:54:12 ET.

Generated by AI

Also Discussed

Investors talking about GHSI also mention

#	Name	Attention
1	TTNP - Titan Pharmaceuticals, Inc.	——
2	iBio, Inc.IBIO	0%0
3	China SXT Pharmaceuticals, Inc.SXTC	0%0
4	Viveve Medical Inc.VIVE	0%0
5	China Pharma Holdings, Inc.CPHI	0%new
6	TBLT - ToughBuilt Industries, Inc.	——
7	NovaBay Pharmaceuticals, Inc.NBY	0%0
8	BIMI - BIMI International Medical Inc.	——
9	DSS Inc.DSS	0%0
10	BIOL - BIOLASE, Inc.	——